COVID-19 INDUCED CARDIOVASCULAR DISEASE: A REVIEW

Abstract

 A new virus called the severe acute respiratory distress syndrome corona virus 2 (SARS-CoV-2) causes corona virus disease 2019 (COVID-19). COVID-19 has so far infected around 670 million individuals worldwide, and it has been linked to about 7 million fatalities. The latest research indicates a relationship between cardiovascular disease (CVD) and COVID-19. Diabetes mellitus and arterial hypertension are risk factors for CVD, and COVID-19 may be an underappreciated CVD risk modifier. Furthermore, new research indicates that prior COVID-19 may raise the risk for other CVD entities to a comparable degree as traditional cardiovascular (CV) risk factors. Moreover, myocarditis, acute coronary syndrome, heart failure (HF), thromboembolic consequences, and arrhythmias have all been linked to adverse clinical results and a higher risk of CVD in those who already had CVD. It has been suggested that COVID-19 may affect CVD and CV risk through both direct and indirect methods, such as viral entrance into CV tissue and the production of a severe systemic inflammatory response. In this review, we sum up the literature in which an interaction between COVID-19 and CVD has been reported, examine possible mechanisms for this interaction, and talk about treatment and prevention approaches and how they affect CVD that have been studied since the COVID 19 pandemic began.